Perfetti's late goal lifts Jets over Avs, 4-2 - newsday.com

Perfetti's late goal lifts Jets over Avs, 4-2  newsday.com

New puberty blockers trial to begin after UK ban - BBC

New puberty blockers trial to begin after UK ban  BBC

Avistone Announces Preclinical Results for ANS03, a Novel Type II ROS1/NTRK Inhibitor in Overcomi...

Avistone Announces Preclinical Results for ANS03, a Novel Type II ROS1/NTRK Inhibitor in Overcoming Clinically Relevant ROS1/NTRK Resistance Mutations at AACR Annual Meeting 2025  BioSpace

Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled...

Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials  Nature

Utility of Digital Twin AI-Generated Models to Improve Patient Selection in Alzheimer Trials - ne...

Utility of Digital Twin AI-Generated Models to Improve Patient Selection in Alzheimer Trials  neurologylive.com

The FDA Has Cleared the First Clinical Trial Application for a Prime Editor - CRISPR Medicine News

The FDA Has Cleared the First Clinical Trial Application for a Prime Editor  CRISPR Medicine News

Coronavirus and Ebola Together Test a Beleaguered Congo - WSJ

Coronavirus and Ebola Together Test a Beleaguered Congo  WSJ

Compass plans IPO to take 'magic mushroom' drug to phase 3 - Fierce Biotech

Compass plans IPO to take 'magic mushroom' drug to phase 3  Fierce Biotech

Clara Health launches initiative to match patients to COVID-19 clinical trials - Fierce Healthcare

Clara Health launches initiative to match patients to COVID-19 clinical trials  Fierce Healthcare

Antibody wipeout found to relieve chronic fatigue syndrome - New Scientist

Antibody wipeout found to relieve chronic fatigue syndrome  New Scientist